NuVasive, Inc.

425 articles with NuVasive, Inc.

• NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch

  7/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that it received its latest U.S. Food and Drug Administration 510 clearance for the Pulse® platform, after receiving CE certification earlier this summer.

• NuVasive Announces Second Quarter 2021 Financial Results

  7/28/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2021.

• NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery

  7/22/2021

  NuVasive, Inc. announced today the commercial launch of Modulus ®  ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.

• NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results

  7/14/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter 2021 earnings results on Wednesday, July 28, 2021, after the close of the market.

• NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations

  6/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that the Pulse® platform received CE Mark approval for its latest design update and clinical evaluations are underway in multiple countries throughout Europe.

• NuVasive Appoints Daniel J. Wolterman as Independent Board Chair

  5/19/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the appointment of Daniel J. Wolterman as independent chair of the NuVasive Board of Directors, effective immediately.

• NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations

  5/10/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Juliet C. Cunningham as the vice president of Investor Relations, effective immediately

• NuVasive Announces First Quarter 2021 Financial Results

  5/5/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2021.

• NuVasive to Present at Upcoming Investor Conferences

  5/3/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the following virtual investor conferences:

• NuVasive Announces Conference Call and Webcast of First Quarter 2021 Results

  4/19/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2021 earnings results on Wednesday, May 5, 2021, after the close of the market.

• NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

  4/6/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR).

• NuVasive Announces Retirement of Gregory T. Lucier from Board of Directors

  3/25/2021

  Mr. Lucier's commitment to disruptive technology and global scale accelerated Company growth to more than $1 billion in net sales

• NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies

  3/16/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International Spine Study Group Foundation (ISSGF) today announced the continuation of their long-term partnership through the launch of two new clinical studies focused on improving patient outcomes in adult spinal deformity surgery.

• NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results

  2/25/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2020.

• NuVasive Acquires Simplify Medical

  2/24/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).

• NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results

  2/11/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the Company will release its fourth quarter and full year 2020 earnings results on Thursday, February 25, 2021, after the close of the market.

• NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area

  2/8/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced the expansion of the Company's Clinical Professional Development and surgeon education program with the planned opening of the NuVasive East Coast Experience Center in Englewood, New Jersey, in third quarter 2021.

• Dr. Siddhartha Kadia to Join NuVasive Board of Directors

  2/1/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Siddhartha Kadia, Ph.D. to the Company's Board of Directors, effective February 1, 2021.

• NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference

  1/7/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 23 rd Annual Needham Virtual Growth Conference on Thursday, January 14, 2021 at 1:15 p.m. ET / 10:15 a.m. P

• NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay

  1/6/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, "Single position circumferential fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion,"